Research on gastric cancer using multiomic data analysis
Taiwan Cancer Moonshot Project: 1. Next-generation Pathway of Taiwan Cancer Precision Medicine (Subjective Aim 1- Taiwan Cancer Moonshot Project); 2. Development of Novel Treatments for Major Diseases (Subproject 5 - Multiomic Big Data-based Intelligent Navigation System for Precision Oncology)
This study is trying to gather and analyze samples from gastric cancer patients to better understand the disease and improve diagnosis and treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 4190 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | Academia Sinica, Taiwan Academic / other |
| Locations | 1 site (Taipei) |
| Trial ID | NCT05248763 on ClinicalTrials.gov |
What this trial studies
This study aims to create a comprehensive multiomic database by collecting clinical samples from patients with gastric cancer and adjacent normal tissues, along with blood samples and clinical data. The research utilizes an integrated proteomics and genetics platform to analyze these samples, focusing on understanding the molecular mechanisms and early interventions for gastric cancer. By employing genome, transcriptome, genomic methylation, and proteomics analyses, the study seeks to enhance precision diagnosis, prognosis, and targeted therapies for gastric cancer patients in Taiwan.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with gastric cancer or other specified cancers such as lung, breast, pancreatic, or ovarian cancer.
Not a fit: Patients with cancer types other than those specified (lung, breast, gastric, pancreatic, or ovarian) may not benefit from this study.
Why it matters
Potential benefit: If successful, this research could lead to improved early diagnosis and targeted treatments for gastric cancer, potentially increasing survival rates.
How similar studies have performed: Other studies utilizing multiomic approaches have shown promise in understanding cancer mechanisms and improving treatment strategies, indicating a potential for success in this novel application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * lung cancer, breast cancer, gastric cancer, pancreatic cancer, ovarian cancer Exclusion Criteria: * other cancer types
Where this trial is running
Taipei
- National Taiwan University Hospital — Taipei, Taiwan (Recruiting)
Study contacts
- Study coordinator: Yu-Ju Chen, PhD
- Email: yujuchen@gate.sinica.edu.tw
- Phone: 886-2-55728660
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.